Sodium-dependent Vitamin C Transporter 2 (SVCT2) expression and activity in brain capillary endothelial cells after transient ischemia in mice

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Gess, Burkhard ^a   Sevimli, Sevgi ^a   Strecker, Jan Kolja ^a   Young, Peter ^a   Schäbitz, Wolf Rüdiger ^a,b  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b EVANGELISCHES KRANKENHAUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CARRIER PROTEIN; CD34 ANTIGEN; OCCLUDIN; SODIUM DEPENDENT VITAMIN C TRANSPORTER 2; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR; SLC23A2 PROTEIN, MOUSE; SODIUM ASCORBIC ACID COTRANSPORTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CAPILLARY; BRAIN ISCHEMIA; CAPILLARY ENDOTHELIUM; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DRUG UPTAKE; ENDOTHELIUM CELL; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; UPREGULATION; ANIMAL; BLOOD BRAIN BARRIER; BRAIN; CEREBRAL ARTERY DISEASE; GENE EXPRESSION REGULATION; METABOLISM; PATHOLOGY; PROTEIN TRANSPORT; TIME; TRANSIENT ISCHEMIC ATTACK; VASCULARIZATION;

ANIMALIA; MUS;

ANIMALS; ASCORBIC ACID; BLOOD-BRAIN BARRIER; BRAIN; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIC ATTACK, TRANSIENT; MALE; MICE; PROTEIN TRANSPORT; SODIUM-COUPLED VITAMIN C TRANSPORTERS; TIME FACTORS; UP-REGULATION;

EID: 79951818058     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017139     Document Type: Article

References (50)

1. Dirnagl U, Iadecola C, Moskowitz MA, (1999) Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22: 391-397.
2. van Gijn J, Dennis MS, (1998) Issues and answers in stroke care. Lancet 352 (Suppl 3): SIII23-27.
3. Heuschmann PU, Kolominsky-Rabas PL, Misselwitz B, Hermanek P, Leffmann C, et al. (2004) Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: the German Stroke Registers Study Group. Arch Intern Med 164: 1761-1768.
4. Rogalewski A, Schabitz WR, (2008) [Development of new stroke therapies: outlook for neuroprotective drugs]. Nervenarzt 79: 218-224.
5. Huang J, May JM, (2006) Ascorbic acid protects SH-SY5Y neuroblastoma cells from apoptosis and death induced by beta-amyloid. Brain Res 1097: 52-58.
6. Avshalumov MV, MacGregor DG, Sehgal LM, Rice ME, (2004) The glial antioxidant network and neuronal ascorbate: protective yet permissive for H(2)O(2) signaling. Neuron Glia Biol 1: 365-376.
7. Qiu S, Li L, Weeber EJ, May JM, (2007) Ascorbate transport by primary cultured neurons and its role in neuronal function and protection against excitotoxicity. J Neurosci Res 85: 1046-1056.
8. Rebec GV, Barton SJ, Marseilles AM, Collins K, (2003) Ascorbate treatment attenuates the Huntington behavioral phenotype in mice. Neuroreport 14: 1263-1265.
9. Rosales-Corral S, Tan DX, Reiter RJ, Valdivia-Velazquez M, Martinez-Barboza G, et al. (2003) Orally administered melatonin reduces oxidative stress and proinflammatory cytokines induced by amyloid-beta peptide in rat brain: a comparative, in vivo study versus vitamin C and E. J Pineal Res 35: 80-84.
10. Wagner GC, Carelli RM, Jarvis MF, (1986) Ascorbic acid reduces the dopamine depletion induced by methamphetamine and the 1-methyl-4-phenyl pyridinium ion. Neuropharmacology 25: 559-561.
11. Huang J, Agus DB, Winfree CJ, Kiss S, Mack WJ, et al. (2001) Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke. Proc Natl Acad Sci U S A 98: 11720-11724.
12. Mack WJ, Mocco J, Ducruet AF, Laufer I, King RG, et al. (2006) A cerebroprotective dose of intravenous citrate/sorbitol-stabilized dehydroascorbic acid is correlated with increased cerebral ascorbic acid and inhibited lipid peroxidation after murine reperfused stroke. Neurosurgery 59: 383-388.
13. Agus DB, Gambhir SS, Pardridge WM, Spielholz C, Baselga J, et al. (1997) Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters. J Clin Invest 100: 2842-2848.
14. Hosoya K, Minamizono A, Katayama K, Terasaki T, Tomi M, (2004) Vitamin C transport in oxidized form across the rat blood-retinal barrier. Invest Ophthalmol Vis Sci 45: 1232-1239.
15. Harrison FE, May JM, (2009) Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. Free Radic Biol Med 46: 719-730.
16. Savini I, Rossi A, Pierro C, Avigliano L, Catani MV, (2008) SVCT1 and SVCT2: key proteins for vitamin C uptake. Amino Acids 34: 347-355.
17. Takanaga H, Mackenzie B, Hediger MA, (2004) Sodium-dependent ascorbic acid transporter family SLC23. Pflugers Arch 447: 677-682.
18. Tsukaguchi H, Tokui T, Mackenzie B, Berger UV, Chen XZ, et al. (1999) A family of mammalian Na+-dependent L-ascorbic acid transporters. Nature 399: 70-75.
19. Caprile T, Salazar K, Astuya A, Cisternas P, Silva-Alvarez C, et al. (2009) The Na+-dependent L-ascorbic acid transporter SVCT2 expressed in brainstem cells, neurons, and neuroblastoma cells is inhibited by flavonoids. J Neurochem 108: 563-577.
20. Garcia Mde L, Salazar K, Millan C, Rodriguez F, Montecinos H, et al. (2005) Sodium vitamin C cotransporter SVCT2 is expressed in hypothalamic glial cells. Glia 50: 32-47.
21. Berger UV, Lu XC, Liu W, Tang Z, Slusher BS, et al. (2003) Effect of middle cerebral artery occlusion on mRNA expression for the sodium-coupled vitamin C transporter SVCT2 in rat brain. J Neurochem 86: 896-906.
22. Hata R, Mies G, Wiessner C, Fritze K, Hesselbarth D, et al. (1998) A reproducible model of middle cerebral artery occlusion in mice: hemodynamic, biochemical, and magnetic resonance imaging. J Cereb Blood Flow Metab 18: 367-375.
23. Sevimli S, Diederich K, Strecker JK, Schilling M, Klocke R, et al. (2009) Endogenous brain protection by granulocyte-colony stimulating factor after ischemic stroke. Exp Neurol 217: 328-335.
24. Mun GH, Kim MJ, Lee JH, Kim HJ, Chung YH, et al. (2006) Immunohistochemical study of the distribution of sodium-dependent vitamin C transporters in adult rat brain. J Neurosci Res 83: 919-928.
25. Ishida H, Takemori K, Dote K, Ito H, (2006) Expression of glucose transporter-1 and aquaporin-4 in the cerebral cortex of stroke-prone spontaneously hypertensive rats in relation to the blood-brain barrier function. Am J Hypertens 19: 33-39.
26. Maher F, Vannucci SJ, Simpson IA, (1994) Glucose transporter proteins in brain. Faseb J 8: 1003-1011.
27. Zhang WW, Zhang L, Hou WK, Xu YX, Xu H, et al. (2009) Dynamic expression of glucose transporters 1 and 3 in the brain of diabetic rats with cerebral ischemia reperfusion. Chin Med J (Engl) 122: 1996-2001.
28. Welch RW, Wang Y, Crossman A Jr, Park JB, Kirk KL, et al. (1995) Accumulation of vitamin C (ascorbate) and its oxidized metabolite dehydroascorbic acid occurs by separate mechanisms. J Biol Chem 270: 12584-12592.
29. Rutkowski M, Grzegorczyk K, Greger J, (2004) Adaptation of the phosphotungstate method to determine reduced and oxidized vitamin C in blood plasma. Z Naturforsch C 59: 762-767.
30. Schorah CJ, Downing C, Piripitsi A, Gallivan L, Al-Hazaa AH, et al. (1996) Total vitamin C, ascorbic acid, and dehydroascorbic acid concentrations in plasma of critically ill patients. Am J Clin Nutr 63: 760-765.
31. Bigley R, Wirth M, Layman D, Riddle M, Stankova L, (1983) Interaction between glucose and dehydroascorbate transport in human neutrophils and fibroblasts. Diabetes 32: 545-548.
32. Washko P, Rotrosen D, Levine M, (1989) Ascorbic acid transport and accumulation in human neutrophils. J Biol Chem 264: 18996-19002.
33. Spector R, (2009) Nutrient transport systems in brain: 40 years of progress. J Neurochem 111: 315-320.
34. Angelow S, Haselbach M, Galla HJ, (2003) Functional characterisation of the active ascorbic acid transport into cerebrospinal fluid using primary cultured choroid plexus cells. Brain Res 988: 105-113.
35. Qiao H, May JM, (2008) Development of ascorbate transporters in brain cortical capillary endothelial cells in culture. Brain Res 1208: 79-86.
36. Ziylan YZ, Diler AS, Lefauconnier JM, Bourre JM, (2006) Evidence for ascorbic acid transport system in rat brain capillaries. Int J Neurosci 116: 25-38.
37. Castro M, Caprile T, Astuya A, Millan C, Reinicke K, et al. (2001) High-affinity sodium-vitamin C co-transporters (SVCT) expression in embryonic mouse neurons. J Neurochem 78: 815-823.
38. Sotiriou S, Gispert S, Cheng J, Wang Y, Chen A, et al. (2002) Ascorbic-acid transporter Slc23a1 is essential for vitamin C transport into the brain and for perinatal survival. Nat Med 8: 514-517.
39. Gess B, Lohmann C, Halfter H, Young P, (2010) Sodium-dependent vitamin C transporter 2 (SVCT2) is necessary for the uptake of L-ascorbic acid into Schwann cells. Glia 58: 287-299.
40. Smith AR, Visioli F, Hagen TM, (2002) Vitamin C matters: increased oxidative stress in cultured human aortic endothelial cells without supplemental ascorbic acid. Faseb J 16: 1102-1104.
41. Qiao H, Li L, Qu ZC, May JM, (2009) Cobalt-induced oxidant stress in cultured endothelial cells: prevention by ascorbate in relation to HIF-1alpha. Biofactors 35: 306-313.
42. Allen CL, Bayraktutan U, (2009) Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int J Stroke 4: 461-470.
43. Wong CH, Crack PJ, (2008) Modulation of neuro-inflammation and vascular response by oxidative stress following cerebral ischemia-reperfusion injury. Curr Med Chem 15: 1-14.
44. Miller AA, Budzyn K, Sobey CG, (2010) Vascular dysfunction in cerebrovascular disease: mechanisms and therapeutic intervention. Clin Sci (Lond) 119: 1-17.
45. Kuroda S, Siesjo BK, (1997) Reperfusion damage following focal ischemia: pathophysiology and therapeutic windows. Clin Neurosci 4: 199-212.
46. Flamm ES, Demopoulos HB, Seligman ML, Poser RG, Ransohoff J, (1978) Free radicals in cerebral ischemia. Stroke 9: 445-447.
47. Jin R, Yang G, Li G, (2010) Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol 87: 779-789.
48. Stevens SL, Bao J, Hollis J, Lessov NS, Clark WM, et al. (2002) The use of flow cytometry to evaluate temporal changes in inflammatory cells following focal cerebral ischemia in mice. Brain Res 932: 110-119.
49. Gieseg SP, Leake DS, Flavall EM, Amit Z, Reid L, et al. (2009) Macrophage antioxidant protection within atherosclerotic plaques. Front Biosci 14: 1230-1246.
50. Henry PT, Chandy MJ, (1998) Effect of ascorbic acid on infarct size in experimental focal cerebral ischaemia and reperfusion in a primate model. Acta Neurochir (Wien) 140: 977-980.